Cite

HARVARD Citation

    Lee, S. et al. (2020). Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm. Expert review of anticancer therapy. 20 (7), pp. 543-550. [Online]. 
  
Back to record